San Rafael, CA, United States of America

Glenn J Dorin


Average Co-Inventor Count = 4.5

ph-index = 9

Forward Citations = 180(Granted Patents)


Location History:

  • San Rafeal, CA (US) (2000 - 2007)
  • San Rafael, CA (US) (1987 - 2010)

Company Filing History:


Years Active: 1987-2010

Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Glenn J Dorin, Pioneering Purification Techniques

Introduction:

Glenn J Dorin, a visionary inventor based in San Rafael, CA, has made significant contributions to the field of biotechnology. With an impressive portfolio of 18 patents, Dorin's innovative approaches have revolutionized the purification and formulation processes in the pharmaceutical industry.

Latest Patents:

One of Dorin's recent patents, "Method of purifying TFPI and TFPI analogs," showcases his expertise in creating highly purified preparations of TFPI or TFPI analogs. The patent outlines a meticulous nine-step method that ensures less than 12% of the molecules are modified species. Additionally, his patent on the "Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor" highlights his ability to develop compositions that are crucial for formulating TFPI.

Career Highlights:

Dorin's stellar career includes notable tenures at Chiron Corporation and Cetus Corporation, where he honed his skills and expertise in biopharmaceuticals. His time at these esteemed companies provided him with the platform to innovate and execute groundbreaking ideas in the realm of biotechnology.

Collaborations:

Throughout his career, Dorin has had the privilege of collaborating with esteemed professionals such as Cynthia A Cowgill and Mark E Gustafson. These collaborations have been instrumental in driving forward his research and innovation efforts, leading to the successful development of novel purification techniques and pharmaceutical formulations.

Conclusion:

Glenn J Dorin's innovative spirit and dedication to advancing biotechnology have solidified his position as a trailblazer in the field. His meticulous approach to purification processes and formulation strategies has not only enhanced the quality of pharmaceutical compositions but has also set new standards for the industry to follow. As he continues to push the boundaries of innovation, the impact of his work is sure to resonate across the biotechnological landscape for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…